Glenmark Pharmaceuticals recalls over 11,000 bottles of Ziac due to potential ezetimibe contamination. The FDA classifies this as a low-risk Class Three recall. Affected tablets range from 2.5mg to 6.25mg and expire from Nov 2025 to Dec 2026. No specific recommendations yet for patients with recalled medication. DNN | The Daily News Now! The world’s first global local news network. Every city. Every story. AI powered. Hosted on Acast. See acast.com/privacy for more information.
